moperone

0 marketed 1 in Phase 2

This page covers all moperone drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting D(4) dopamine receptor, D(2) dopamine receptor, D(3) dopamine receptor.

Targets

D(4) dopamine receptor, D(2) dopamine receptor, D(3) dopamine receptor

Phase 2 pipeline (1)

Patent intelligence